Skip to main content
. Author manuscript; available in PMC: 2017 Feb 2.
Published in final edited form as: Genet Med. 2012 Jun 14;14(10):833–835. doi: 10.1038/gim.2012.64

Table 1. Research use of customer samples and data.

Decodea Pathwayb Navigenicsc 23andMed before IRB consult 23andMee,f after IRB consult
Customers who purchase genotyping must also consent to research No No Yes Yes No
Customer samples are used for internal research (e.g., quality control) N/A Yes Yes Yes Yes
Customer samples are used for research for general knowledge N/A No Yes Yes Yes
Customers are required to sign legal waivers covering research participation N/A N/A Yes Yes No
Human subjects research is reviewed by ethics committee or IRB N/A N/A ND CO Yes

CO, human subjects review is required for outside collaborators only; IRB, institutional review board; N/A, not applicable because company does not do research on customer samples; ND, not described on website.

Information drawn from company websites:

a

deCODEme Genetic Scan Service Agreement and Informed Consent, 2010. http://www.decodeme.com/service-agreement. Accessed 2 August 2010.

b

Pathway Genomics Privacy Policy, 2012. https://www.pathway.com/about-us/privacy-policy. Accessed 28 April 2012.

c

Navigenics Informed Consent, Health Compass, 2010. http://www.navigenics.com/visitor/what_we_offer/our_policies/informed_consent/health_compass/. Accessed 2 August 2010.

d

23andMe. Claim Your Kit. Consent and Legal Agreement, 2010. No longer posted in original form. Version 1.3 (identical to original with additional section). https://www.23andme.com/about/consent/?version=1.3. Accessed 3 August 2010.

e

23andMe. Consent Document, 2010. https://www.23andme.com/about/consent/. Accessed 3 August 2010.

f

23andMe. Privacy Statement, 2010. https://www.23andme.com/about/privacy/. Accessed 2 August 2010; 23andMe. Summary of Changes to the 23andMe Privacy Statement, 2010. No longer posted. Accessed 27 June 2010.